West Pharmaceutical Services: Still Too Expensive After The Recent Drop [Seeking Alpha]
West Pharmaceutical Services, Inc. (WST)
Last west pharmaceutical services, inc. earnings: 4/23 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investor.westpharma.com
Company Research
Source: Seeking Alpha
In its most recent Q4 2023 results, the company put up relatively flat growth, and a continuation of the trend is expected in 2024. While the company benefits long-term from secular tailwinds, the valuation is far too expensive for a single-digit growth company, especially after a 51% rise in the share price in 2023. Introduction West Pharmaceutical Services, Inc. ( NYSE: WST ) is a market leader in the injectables market, benefitting from long-term tailwinds as more biologics get introduced to the market and healthcare spending ramps up. On February 15, the company announced its Q4 2023 results (which were pretty mixed) and provided guidance and outlook for 2024. In this article, I'll delve deeper into the company's results and provide a rationale for why I'm not buying the company's shares after a drop in its share price post-results. Background Over the last ten years, shares of West Pharmaceutical have put up very respectable returns to investors with a total return of
Show less
Read more
Impact Snapshot
Event Time:
WST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WST alerts
High impacting West Pharmaceutical Services, Inc. news events
Weekly update
A roundup of the hottest topics
WST
News
- West Pharmaceutical Services, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions [Yahoo! Finance]Yahoo! Finance
- Fill Finish Manufacturing Market is Expected to Reach $25.7 billion | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- West Pharmaceutical Services First Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]Yahoo! Finance
- West Pharmaceutical (WST) Q1 Earnings Beat, HVP Sales Weak [Yahoo! Finance]Yahoo! Finance
- West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend [Yahoo! Finance]Yahoo! Finance
WST
Earnings
- 4/25/24 - Beat
WST
Sec Filings
- 4/26/24 - Form 8-K
- 4/25/24 - Form 4
- 4/25/24 - Form 4
- WST's page on the SEC website